-+ 0.00%
-+ 0.00%
-+ 0.00%

*Amylyx Pharmaceuticals Plans to Use Net Proceeds for Precommercial Activities, R&D, Working Capital, Other General Corporate Purposes >AMLX

Dow Jones·08/20/2026 03:13:00

Please log in to view news